glutathione and brain neurodegenerative diseases: immunopharmacological implications Unlocking the Potential of Intravenous

Clin Cancer Res 11 : 49124922 Munster P, Marchion D, Bicaku E, Schmitt M, Lee JH, DeConti R, Simon G, Fishman M, Minton S, Garrett C, Chiappori A, Lush R, Sullivan D, Daud A (2007) Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study

As well, lipopolysaccharide (LPS), a component of the outer membrane of certain bacteria, can induce an immune response and neuroinflammation for PD (Tufekci et al

"Oral sulforaphane increases Phase II antioxidant enzymes in the human upper airway." Clin Immunol

However, clinical experience and studies provide guidance on common dosing regimens

Most peptides degrade rapidly when exposed to stomach acid or digestive enzymes

Griffiths S, Sherman EMS, Strauss E